Bioengineering strategies for inducing tolerance in autoimmune diabetes
- 1 May 2017
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 114, 256-265
Abstract
No abstract availableKeywords
Funding Information
- Juvenile Diabetes Research Foundation Faculty Transition Award (1-FAC-2017-367-A-N, 2-SRA-2016-315-S-B)
- Research Grant
- Intramural Research Program of EPFL's School of Life Sciences
This publication has 133 references indexed in Scilit:
- Engineering antigens for in situ erythrocyte binding induces T-cell deletionProceedings of the National Academy of Sciences, 2012
- Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitisNature Biotechnology, 2012
- Virus Infections in Type 1 DiabetesCold Spring Harbor Perspectives in Medicine, 2011
- Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying CellsImmunity, 2011
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesNature Materials, 2011
- Chromogranin A is an autoantigen in type 1 diabetesNature Immunology, 2010
- Immunogenic and tolerogenic cell deathNature Reviews Immunology, 2009
- ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanismsProceedings of the National Academy of Sciences, 2008
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008